EN – Press release TBCCB acquisition

November 3, 2010 Group News

Acquisition of distributor

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has acquired its Bulgarian distributor, Tissue Bank Cryo Center Bulgaria AD (‘TBCCB’) for an initial consideration of €1.5 million payable in cash and 100,000 Cryo-Save Group N.V. shares, and a deferred performance payment, payable annually on the achievement of certain goals until 2013. The total acquisition price reflects approximately five times EBIT of TBCCB. The Group expects the acquisition to be earnings enhancing with immediate effect.

read more

NL – Press release TBCCB acquisition

November 3, 2010 Group News

Overname van distributeur

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, heeft zijn Bulgaarse distributeur, Tissue Bank Cryo Center Bulgaria AD (‘TBCCB’), geacquireerd. De overnameprijs bedraagt €1,5 miljoen in contanten en 100.000 aandelen Cryo-Save Group N.V. Daarnaast is gedurende drie jaar een resultaatafhankelijke betaling verschuldigd. De totale acquisitieprijs weerspiegelt ongeveer vijf maal de EBIT van TBCCB. Cryo-Save verwacht dat de acquisitie met onmiddellijke ingang bijdraagt aan de winst per aandeel.

read more

Completion of Acquisition

July 14, 2009 Group News

Completion of Acquisition of Italian service company

Further to the announcement made on 27 May 2009, Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, is pleased to announce the completion of the acquistion of Salus Futura Ltd, which holds all shares of Salus Futura Srl, Italy (“Salus Futura”), following the signing of the sale and purchase agreement and transfer of the initial consideration of €0.4 million in return for Salus Futura shares on 10 July 2009.

read more

Acquisition of italian service company

May 27, 2009 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that it has agreed to acquire Salus Futura Ltd, United Kingdom, which holds all shares of Salus Futura Srl, Italy (“Salus Futura”), for an initial consideration of €0.4 million payable in cash and a deferred performance related payment, payable annually on the achievement of certain goals until 31 May 2012. The total consideration under the agreement has been capped to avoid the need for shareholder approval. Cryo-Save expects the acquisition to be earnings enhancing on completion.

read more

Acquisition of leading balkan distributor

July 22, 2008 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save”, or “the Group”), Europe’s leading adult stem cell storage bank, has acquired Cryo-Save Balcanica S.A. (“Cryo-Save Balcanica”) of Athens, for an initial consideration of €4.1 million payable in cash. The acquisition of the Group’s leading distributor in the Balkans, provides Cryo-Save with a platform for further strong growth and increased profitability, and is expected to be earnings enhancing with immediate effect.

read more

Acquisition of leading spanish distributor

July 8, 2008 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading adult stem cell storage bank, has acquired its Spanish distributor, Crio Cord, S.L. (“Crio Cord”) for an initial consideration of €16 million payable in cash and a deferred performance payment, payable annually on the achievement of certain goals until 2011. Cryo-Save expects the acquisition to be earnings enhancing with immediate effect.

read more